期刊文献+

Morphology and structural dynamics of amyloid beta 42 assembly in vitro

Morphology and structural dynamics of amyloid beta 42 assembly in vitro
下载PDF
导出
摘要 Amyloid β42 (Aβ42) aggregation plays a key role in the pathogenesis of Alzheimer’s disease. However, the morphology and structural dynamics in different stages of Aβ42 assembly are not well known. To investigate the dynamic properties of morphological and structural changes in the aggregation process of Aβ in vitro, transmission electron microscopy, western blot analysis and circular dichroism were used to observe the changes in morphology, immunoreactivity and secondary structure during Aβ aggregation, respectively. Results demonstrated that at 24 hours following Aβ42 aggregation in vitro, the structures of spherical granules from 5 to 10 nm and coils from 20 to 30 nm were visualized by transmission electron microscopy. Different immunoreactivities of the oligomers and fibers were detected by western blot analysis. The dynamic changes of the α-helix to β-sheet were confirmed by circular dichroism spectra. The dynamic properties of the morphological and structural changes in the aggregation process of Aβ42 in vitro were analyzed, which contributed to the identification of stable conditions of Aβ42 oligomer formation. Amyloid β42 (Aβ42) aggregation plays a key role in the pathogenesis of Alzheimer's disease. However, the morphology and structural dynamics in different stages of Aβ42 assembly are not well known. To investigate the dynamic properties of morphological and structural changes in the aggregation process of Aβ in vitro, transmission electron microscopy, western blot analysis and circular dichroism were used to observe the changes in morphology, immunoreactivity and secondary structure during Aβ aggregation, respectively. Results demonstrated that at 24 hours following Aβ42 aggregation in vitro, the structures of spherical granules from 5 to 10 nm and coils from 20 to 30 nm were visualized by transmission electron microscopy. Different immunoreactivities of the oligomers and fibers were detected by western blot analysis. The dynamic changes of the α-helix to β-sheet were confirmed by circular dichroism spectra. The dynamic properties of the morphological and structural changes in the aggregation process of Aβ42 in vitro were analyzed, which contributed to the identification of stable conditions of Aβ42 oligomer formation.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2011年第5期335-339,共5页 中国神经再生研究(英文版)
基金 Supported by the State Plan for High-Tech Research and Development (863 Project), No. 2006AA02A247 the Scientific and Technological Major Special Project of China, No. 2009ZX10004-216 Fundamental Research Funds for the Central Universities, No. 2011JBM124
关键词 Β淀粉样蛋白 结构动力学 体外装配 形态学 透射电子显微镜 免疫印迹分析 阿尔茨海默氏病 电子显微镜观察 Alzheimefs disease Aβ oligomer transmission electron microscopy western blot circular dichroism
  • 相关文献

参考文献38

  • 1Lambert MP, Barlow AK, Chromy BA, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A. 1998;95(11):6448-6453.
  • 2Lacor PN, Buniel MC, Furlow PW, et al. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease. J Neurosci. 2007;27(4):796-807.
  • 3De Felice FG, Velasco PT, Lambert MP, et al. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J Biol Chem. 2007;282(15):11590-11601.
  • 4Lashuel HA, Hartley DM, Balakhaneh D, et al. New class of inhibitors of amyloid-beta fibril formation: implications for the mechanism of pathogenesis in Alzheimer's disease. J Biol Chem. 2002;277(45):42881-42890.
  • 5Necula M, Kayed R, Milton S, et al. Small molecule inhibitors of aggregation indicate that amyloid beta oligomerization and fibrillization pathways are independent and distinct. J Biol Chem. 2007;282(14):10311 -10324.
  • 6Hare J. Trafficking of amyloid beta-precursor protein products C83 and C99 on the endocytic pathway. Biochem Biophys Res Commun. 2010;401 (2):219-224.
  • 7Bitan G, Lomakin A, Teplow DB. Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem. 2001 ;276(37):35176-35184.
  • 8Bitan G, Kirkitadze MD, Lomakin A, et al. Amyloid beta-protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A. 2003;100(1): 330-335.
  • 9Kawasaki T, Onodera K, Kamijo S. Selection of peptide inhibitors of soluble aβ(1-42) oligomer formation by phage display. Biosci Biotechnol Biochem. 2010;74(11):2214-2219.
  • 10Murata N, Murakami K, Ozawa Y, et al. Silymarin attenuated the Amyloid β plaque burden and improved behavioral abnormalities in an Alzheimer's disease mouse model. Biosci Biotechnol Biochem. 2010;74(11):2299-2306.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部